Regardless of a viral, autoimmune, or chemotherapy-induced trigger, many inflammatory cardiac diseases converge on NLRP3 activation and the release of pro-inflammatory cytokines such as IL-1β and IL-18. The gene discussed is IL1B; the disease is heart disorder.